161 related articles for article (PubMed ID: 1583106)
21. Relationships between titers of antibodies immunoreacting against glycolipid antigens from Mycobacterium leprae and M. tuberculosis, the Mitsuda and Mantoux reactions, and bacteriological loads: implications in the pathogenesis, epidemiology and serodiagnosis of leprosy and tuberculosis.
David HL; Papa F; Cruaud P; Berlie HC; Maroja MF; Salem JI; Costa MF
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):208-24. PubMed ID: 1522363
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of recombinant serine-rich 45-kDa antigen (ML0411) for detection of antibodies in leprosy patients.
Parkash O; Kumar A; Nigam A; Franken KL; Ottenhoff TH
Scand J Immunol; 2006 Oct; 64(4):450-5. PubMed ID: 16970689
[TBL] [Abstract][Full Text] [Related]
23. Comparison of synthetic antigens for detecting antibodies to phenolic glycolipid I in patients with leprosy and their household contacts.
Chanteau S; Cartel JL; Roux J; Plichart R; Bach MA
J Infect Dis; 1988 Apr; 157(4):770-6. PubMed ID: 3346568
[TBL] [Abstract][Full Text] [Related]
24. Anti-Lipoarabinomannan-Specific Salivary IgA as Prognostic Marker for Leprosy Reactions in Patients and Cellular Immunity in Contacts.
Nahas AA; Lima MIS; Goulart IMB; Goulart LR
Front Immunol; 2018; 9():1205. PubMed ID: 29904387
[TBL] [Abstract][Full Text] [Related]
25. Antibody responses to the 18-kDa protein of Mycobacterium leprae in leprosy and tuberculosis patients.
Roche PW; Prestidge RL; Watson JD; Britton WJ
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):201-7. PubMed ID: 1381739
[TBL] [Abstract][Full Text] [Related]
26. Gelatin particle agglutination assay to detect anti-PGL-I antibodies in leprosy patients and in household contacts: a preliminary study.
Mahajan P; Jogaikar DG; Jadhav VH; Mehta JM
Indian J Lepr; 1992; 64(4):461-7. PubMed ID: 1308520
[TBL] [Abstract][Full Text] [Related]
27. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364
[TBL] [Abstract][Full Text] [Related]
28. Serological specificity of phenolic glycolipid I from Mycobacterium leprae and use in serodiagnosis of leprosy.
Cho SN; Yanagihara DL; Hunter SW; Gelber RH; Brennan PJ
Infect Immun; 1983 Sep; 41(3):1077-83. PubMed ID: 6193065
[TBL] [Abstract][Full Text] [Related]
29. A study on a possibility of predicting early relapse in leprosy using a ND-O-BSA based ELISA.
Wu Q; Yin Y; Zhang L; Chen X; Yu Y; Li Z; Yu H; Lu C; Feng S; Li X; Huo W; Ye G
Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):1-8. PubMed ID: 12120035
[TBL] [Abstract][Full Text] [Related]
30. Anti-PGL1 salivary IgA/IgM, serum IgG/IgM, and nasal Mycobacterium leprae DNA in individuals with household contact with leprosy.
Brito e Cabral P; Júnior JE; de Macedo AC; Alves AR; Gonçalves TB; Brito e Cabral TC; Gondim AP; Pinto MI; Oseki KT; Camara LM; Rabenhorst SH; Nagao-Dias AT
Int J Infect Dis; 2013 Nov; 17(11):e1005-10. PubMed ID: 23871279
[TBL] [Abstract][Full Text] [Related]
31. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
32. Use of synthetic glycoconjugates containing the Mycobacterium leprae specific and immunodominant epitope of phenolic glycolipid I in the serology of leprosy.
Brett SJ; Payne SN; Gigg J; Burgess P; Gigg R
Clin Exp Immunol; 1986 Jun; 64(3):476-83. PubMed ID: 2431812
[TBL] [Abstract][Full Text] [Related]
33. Circulating immune complexes in leprosy sera: demonstration of antibodies against mycobacterial glycolipidic antigens in isolated immune complexes.
Yamashita JT; Cruaud P; Papa F; Rotta O; David HL
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):44-50. PubMed ID: 8326180
[TBL] [Abstract][Full Text] [Related]
34. IgM and IgG antibodies to phenolic glycolipid I from Mycobacterium leprae in leprosy: insight into patient monitoring, erythema nodosum leprosum, and bacillary persistence.
Levis WR; Meeker HC; Schuller-Levis G; Sersen E; Schwerer B
J Invest Dermatol; 1986 May; 86(5):529-34. PubMed ID: 3528312
[TBL] [Abstract][Full Text] [Related]
35. Identification of mycobacterial antigens for "ELISA" serology in the diagnosis of leprosy and tuberculosis.
Das PK; Rambukkana A; Bass JG; Groothuis DG; Kok A; Halperin M
Acta Leprol; 1989; 7 Suppl 1():117-20. PubMed ID: 2503964
[TBL] [Abstract][Full Text] [Related]
36. Serum anti-phenolic glycolipid-1 IgA correlates to IgM isotype in leprosy patients: a possible candidate for seroepidemiological surveys?
de Macedo AC; Guimarães JA; Rodrigues RO; Araújo TDV; Tavares CM; Cabral PB; de Moraes-Pinto MI; Nagao-Dias AT
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28594117
[TBL] [Abstract][Full Text] [Related]
37. Anti-PGL-1 antibody levels in Thai leprosy patients.
Kampirapap K; Singtham N
Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):728-33. PubMed ID: 9253875
[TBL] [Abstract][Full Text] [Related]
38. Antibodies to phenolic glycolipid-I during long-term therapy: serial measurements in individual patients.
Miller RA; Gorder D; Harnisch JP
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):633-6. PubMed ID: 3323367
[TBL] [Abstract][Full Text] [Related]
39. Use of anti-M. leprae phenolic glycolipid-I antibody detection for early diagnosis and prognosis of leprosy.
Agis F; Schlich P; Cartel JL; Guidi C; Bach MA
Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):527-35. PubMed ID: 3065419
[TBL] [Abstract][Full Text] [Related]
40. Specific anti-M leprae PGL-I antibodies and Mitsuda reaction in the management of household contacts in New Caledonia.
Desforges S; Bobin P; Brethes B; Huerre M; Moreau JP; Bach MA
Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):794-800. PubMed ID: 2681462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
